Atlas Trials

Sintilimab Combined With Modified FLOT Regimen in the Treatment of Metastatic Gastric Cancer

Clinical trial NCT05982301 · UNKNOWN

Trial details

NCT number
NCT05982301
Sponsor
Fudan University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Gastric CancerChemotherapy EffectImmune Checkpoint Inhibitor
Start date
2023-02-09
Primary completion
2025-01-01
Enrollment
87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.